Section for Pathology, The Gade Institute, University of Bergen, Haukeland University Hospital, N-5021, Bergen, Norway.
Br J Cancer. 2010 Jan 19;102(2):369-75. doi: 10.1038/sj.bjc.6605488. Epub 2009 Dec 15.
Putative breast cancer stem cells might express surface markers such as aldehyde dehydrogenase 1 (ALDH1) and BMI-1 proteins. The aim of this study was to explore the expression of these proteins in breast cancers from an African population and their associations with the basal-like phenotype (BLP) and other molecular characteristics.
We analysed 192 paraffin-embedded breast carcinoma samples by tissue microarrays and immunohistochemical methods.
In total, 88 tumours (48%) expressed ALDH1, whereas 46 (25%) expressed BMI-1 protein. Expression of ALDH1 was associated with high histological grade (P<0.0005), high mitotic count (P<0.0005), high nuclear grade (P<0.0005), oestrogen receptor (ER) negativity (P<0.0005), progesterone receptor (PR) negativity (P=0.009), p53 expression (P=0.034), cytokeratin 5/6 positivity (P=0.008), epidermal growth factor receptor (EGFR) expression (P=0.015) and the BLP (P<0.0005), whereas it was inversely associated with BMI-1 staining (P=0.009). On the other hand, BMI-1 expression was associated with low histological grade (P=0.004) and ER positivity (P=0.001).
There was a high prevalence of ALDH1 expression among breast carcinomas and associations with basal markers and features of aggressive tumours. Studies are required to elucidate the importance of these findings for improved understanding of breast cancer biology.
乳腺癌干细胞可能表达表面标志物,如醛脱氢酶 1(ALDH1)和 BMI-1 蛋白。本研究旨在探讨这些蛋白在非洲人群乳腺癌中的表达及其与基底样表型(BLP)和其他分子特征的关系。
我们通过组织微阵列和免疫组织化学方法分析了 192 例石蜡包埋的乳腺癌样本。
总共有 88 个肿瘤(48%)表达 ALDH1,而 46 个肿瘤(25%)表达 BMI-1 蛋白。ALDH1 的表达与高组织学分级(P<0.0005)、高有丝分裂计数(P<0.0005)、高核级(P<0.0005)、雌激素受体(ER)阴性(P<0.0005)、孕激素受体(PR)阴性(P=0.009)、p53 表达(P=0.034)、细胞角蛋白 5/6 阳性(P=0.008)、表皮生长因子受体(EGFR)表达(P=0.015)和 BLP(P<0.0005)相关,而与 BMI-1 染色呈负相关(P=0.009)。另一方面,BMI-1 的表达与低组织学分级(P=0.004)和 ER 阳性(P=0.001)相关。
乳腺癌中 ALDH1 的表达率较高,与基底标志物和侵袭性肿瘤特征相关。需要进一步研究这些发现的重要性,以更好地了解乳腺癌生物学。